Navigating Cancer

Get the answers to your top seven lymphocyte count questions from a blood work expert.

Our host speaks with three neuro-oncologists about glioma treatments by stage. They talk symptom management, key patient questions, and the latest advancements in care and trials.

In this segment, our host speaks with three neuro-oncologists on IDH mutations. They discuss testing, retesting, and the impact of other genetic mutations on treatment.

Expert interviews three neuro-oncologists to discuss glioma brain tumors, covering their definition, causes, risk factors, symptoms, and the importance of multidisciplinary care.

In this series of three videos, Kim Wallgren, of the CERN Foundation, a program of the National Brain Tumor Society, talks to three specialists about brain cancer, specifically glioma.

Ruth Fein, a patient with an MPN, reflects on the challenges of having a chronic cancer for 30 years and what facing another year means for her.

Here are Patient Power’s most-clicked pages from the past year.

Two patient advocates discuss how far treatment has come and the excitement of hearing the word “cure” being discussed by researchers.

Michele Nadeem-Baker and Cindy Chmielewski discuss creating support groups, online resources, and how to find accurate information about your condition.

In this replay, Patient Power co-founders discuss strategies for planning travel and communicating your plans with your medical team.

In this replay of a recent Answers Now live show, Patient Power hosts and patient advocates host a celebratory end of year program.

ASH leaders outlined key clinical research on blood cancers and themes that will be featured during the 2024 annual meeting. Here’s what to watch for this year.